Hsbc Holdings PLC Enanta Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

A detailed history of Hsbc Holdings PLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 18,086 shares of ENTA stock, worth $181,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,086

Previous 20,389 11.3%

Holding current value

$181,764

Previous $355,000 34.08%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$11.43 - $17.02 $26,323 - $39,197	-2,303 Reduced 11.3%	18,086 $234,000
Q1 2024 May 15, 2024	SELL	$10.08 - $17.46 $59,935 - $103,817	-5,946 Reduced 22.58%	20,389 $355,000
Q4 2023 Feb 12, 2024	BUY	$8.18 - $10.78 $130,462 - $171,930	15,949 Added 153.56%	26,335 $247,000
Q3 2023 Nov 13, 2023	BUY	$11.09 - $22.13 $115,180 - $229,842	10,386 New	10,386 $116,000
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $57,159 - $75,329	1,402 Added 24.42%	7,144 $332,000
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $687,166 - $1.01 Million	-14,230 Reduced 71.25%	5,742 $302,000
Q2 2022 Aug 11, 2022	SELL	$38.13 - $76.93 $13,421 - $27,079	-352 Reduced 1.73%	19,972 $950,000
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $171,263 - $226,406	3,055 Added 17.69%	20,324 $1.47 Million
Q4 2021 Feb 11, 2022	BUY	$60.19 - $97.37 $322,919 - $522,390	5,365 Added 45.07%	17,269 $1.29 Million
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $82 - $117	-2 Reduced 0.02%	11,904 $681,000
Q2 2021 Aug 13, 2021	BUY	$43.76 - $53.11 $521,006 - $632,327	11,906 New	11,906 $523,000
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $219,664 - $289,531	-5,269 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $1,358 - $1,566	33 Added 0.63%	5,269 $221,000
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $652,958 - $806,108	-15,059 Reduced 74.2%	5,236 $238,000
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $941,079 - $1.17 Million	20,295 New	20,295 $1.02 Million
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $592,842 - $913,880	-14,740 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$57.95 - $66.61 $854,183 - $981,831	14,740 New	14,740 $914,000

Others Institutions Holding ENTA

# of Institutions

Shares Held

21.2M

Call Options Held

10.4K

Put Options Held

2.3K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $208M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Enanta Pharmaceuticals Inc Transaction History